Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.71215 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Yulia Balmakov und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel. Hauptthemen laut MEDLINE: Diabetes, Gestational, Polycystic Ovary Syndrome, Metabolic Syndrome. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Aims
Evaluating the association between polyendocrine metabolic ovarian syndrome (PMOS), traditionally termed polycystic ovary syndrome, and the broad spectrum of gestational dysglycemia in a large, universally screened population. Materials and Methods This retrospective cohort study used routinely collected data linked from Israeli military pre‐recruitment medical evaluation (ages 16–19) and Maccabi Healthcare Services electronic health records, including two‐step GDM screening during the first pregnancy, 2001–2019. Outcome was categorised into gestational normoglycemia, abnormal glucose challenge test (GCT) with a normal oral glucose tolerance test (OGTT), gestational impaired glucose tolerance (GIGT) and gestational diabetes mellitus (GDM). Multivariable logistic models were adjusted for birth year, adolescent BMI, socioeconomic position, country of birth, cognitive performance, education and age at GDM screening.
Results
Among 177 241 women, 13 648 (7.7%) had PMOS. Rates (95% CI) of abnormal GCT with normal OGTT, GIGT, GDM and any dysglycemia were 9.1% (8.6–9.6) versus 7.9% (7.8–8.0), 4.9% (4.5–5.3) versus 4.0% (3.9–4.1), 6.3% (5.9–6.7) versus 4.2% (4.1–4.3) and 20.3% (19.6–21.0) versus 16.1% (16.0–16.3) among women with versus without PMOS, respectively. Corresponding adjusted ORs (95% CI) were 1.18 (1.11–1.26), 1.26 (1.16–1.37), 1.61 (1.49–1.73) and 1.31 (1.25–1.37), respectively. An interaction was observed with the highest odds among women with both PMOS and high adolescent BMI (adjusted OR 1.77, 95% CI: 1.52–2.10).
Conclusions
Women with PMOS, and particularly those with concomitantly high BMI, constitute a high‐risk subgroup for subthreshold gestational dysglycemia and GDM, highlighting the importance of pre‐pregnancy mitigation of modifiable risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Military Medicine, Hebrew University of Jerusalem, Faculty of Medicine, Jerusalem, Israel.
- Israel Defense Forces, Medical Corps, Ramat Gan, Israel.
- Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, North Carolina, USA.
- Department of Epidemiology and Preventive Medicine, School of Public Health, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
- Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- School of Medicine, The Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Hertzel C Gerstein, Gabriel Chodick, Tali Cukierman-Yaffe, Gilad Twig, Adi Vinograd
Zitieren
APA
Balmakov, Y., Nitecki, M., Gerstein, H. C., Pinhas-Hamiel, O., Chodick, G., Derazne, E., Barer, Y., Gruber, N., Bardugo, A., Bendor, C. D., Shina, A., Afek, A., Cukierman-Yaffe, T., Twig, G., & Vinograd, A. (2026). Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71215
Vancouver
Balmakov Y, Nitecki M, Gerstein HC, Pinhas-Hamiel O, Chodick G, Derazne E, et al. Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71215
BibTeX
@article{Balmakov2026,
author = {Balmakov, Yulia and Nitecki, Maya and Gerstein, Hertzel C and Pinhas-Hamiel, Orit and Chodick, Gabriel and Derazne, Estela and Barer, Yael and Gruber, Noah and Bardugo, Aya and Bendor, Cole D and Shina, Avi and Afek, Arnon and Cukierman-Yaffe, Tali and Twig, Gilad and Vinograd, Adi},
title = {Polyendocrine Metabolic Ovarian Syndrome and the Entire Spectrum of Gestational Dysglycemia: A Population‐Based Cohort Study},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.71215}
}
EUVIMED